Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.38 EUR | +0.85% | -0.83% | +27.96% |
Apr. 03 | Vytrus Biotech, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Vytrus Biotech, S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2024 * | 4.58M 4.96M | Sales 2025 * | - | Capitalization | 16.03M 17.38M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.73 x |
Net Debt 2024 * | 1.03M 1.12M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
21.6
x | P/E ratio 2025 * |
-
| Employees | 35 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 38.67% |
1 day | +0.85% | ||
1 week | -0.83% | ||
Current month | +0.85% | ||
1 month | -1.65% | ||
3 months | +19.00% | ||
6 months | +19.60% | ||
Current year | +27.96% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Jané Font
CEO | Chief Executive Officer | - | 08-12-31 |
Chief Executive Officer | - | 08-12-31 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 08-12-31 | |
Albert Jané Font
CEO | Chief Executive Officer | - | 08-12-31 |
Director/Board Member | - | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 2.38 | +0.85% | 42,100 |
24-05-23 | 2.36 | 0.00% | 40 |
24-05-22 | 2.36 | +3.51% | 375,745 |
24-05-21 | 2.28 | -5.00% | 5,600 |
24-05-20 | 2.4 | 0.00% | 0 |
Delayed Quote BME, May 24, 2024 at 10:00 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+27.96% | 17.4M | |
+25.94% | 70.61M | |
-24.59% | 65.45M |
- Stock Market
- Equities
- VYT Stock